---
title: "HWHG: The injectable remimazolam benzenesulfonate has received a drug registration certificate for new indications"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254396889.md"
description: "HWHG's subsidiary Yichang HWHG Pharmaceutical recently obtained the drug registration certificate for injectable remimazolam besylate approved by the National Medical Products Administration, with a new indication for sedation during mechanical ventilation in intensive care. The drug was jointly developed by Yichang HWHG and the German company PAION, and the market sales are expected to reach 250 million yuan in 2024. This approval will expand the product's usage scope and bring positive impacts"
datetime: "2025-08-25T08:48:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254396889.md)
  - [en](https://longbridge.com/en/news/254396889.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254396889.md)
generator: "portal-rs"
---

# HWHG: The injectable remimazolam benzenesulfonate has received a drug registration certificate for new indications

HWHG announced that its holding subsidiary Yichang Renfu Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" for injectable remimazolam besylate approved by the National Medical Products Administration. The new indication for this drug is: "used as a sedative during mechanical ventilation in intensive care." Injectable remimazolam besylate is a new type of benzodiazepine developed jointly by Yichang Renfu and the German company PAION, and it is an ultra-short-acting GABAa receptor agonist. So far, approximately RMB 20 million has been invested in this project. The market sales of this drug are expected to be around RMB 250 million in 2024. The approval of this new indication is beneficial for expanding the usage scope of this product and will have a positive impact on the company

### Related Stocks

- [600079.CN](https://longbridge.com/en/quote/600079.CN.md)

## Related News & Research

- [US to award $389 million in R&D funds for power semiconductors, critical materials](https://longbridge.com/en/news/302719897.md)
- [GRAPHIC-Take Five: AI trade meets the Fed](https://longbridge.com/en/news/302836715.md)
- [U.S. oil exports to Asia plunge as war disrupts shipping, lifting tanker rates to record high](https://longbridge.com/en/news/302792281.md)
- [Iran Is 'Doing Everything They Can to Drive Up' Oil Prices, Says Trump](https://longbridge.com/en/news/302765449.md)
- [Western Digital Q1 Revenue Surges 55% YoY, Shares Drop Nearly 7%: Can $330 Support Hold?](https://longbridge.com/en/news/302840204.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**